Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enbrel for Idiopathic Pneumonia Syndrome after HCT
NCT00421174Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Aug 2007
- Primary completion
- Jun 2010
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in Idiopathic Pneumonia Syndrome (IPS), sponsored by National Heart, Lung, and Blood Institute. Started Aug 2007; status: completed.
02
Drugs
etanercept
03
Conditions
Idiopathic Pneumonia Syndrome (IPS)
Beyond the preview
Go deeper on NCT00421174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421174.